Therapeutic Protocols Using Ketamine and Esketamine for Depressive Disorders: A Systematic Review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Therapeutic Protocols Using Ketamine and Esketamine for Depressive Disorders: A Systematic Review

Published:2023-08-28 Issue: Volume: Page:1-17
ISSN:0279-1072
Container-title:Journal of Psychoactive Drugs
language:en
Short-container-title:Journal of Psychoactive Drugs

Author:

K. Freind Julia M.¹,Beserra Fernando R.¹^ORCID,Menezes Bruno S.²,Mograbi Daniel C.¹³

Affiliation:

1. Department of Psychology, Pontifical Catholic University of Rio de Janeiro (PUC-Rio), Rio de janeiro, Brazil

2. Institute of Psychiatry, Federal University of Rio de Janeiro (UFRJ), Rio de janeiro, Brazil

3. Institute of Psychiatry,Psychology & Neuroscience, King’s College London, London, UK

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro

Scirama

Publisher

Informa UK Limited

Subject

General Psychology,Medicine (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.1080/02791072.2023.2248989

Reference81 articles.

1. Treatment-resistant depression: therapeutic trends, challenges, and future directions

2. Does oral administration of ketamine accelerate response to treatment in major depressive disorder? Results of a double-blind controlled trial

3. Ketamine for Bipolar Depression: Biochemical, Psychotherapeutic, and Psychedelic Approaches

4. Antidepressant effects of ketamine in depressed patients

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Public Reactions to Communication of Uncertainty: How Long-Term Benefits Can Outweigh Short-Term Costs;Public Opinion Quarterly;2024-04-17

2. The role and mechanism of esketamine in preventing and treating remifentanil-induced hyperalgesia based on the NMDA receptor–CaMKII pathway;Open Life Sciences;2024-01-01

3. Stimulant and hallucinogenic novel psychoactive substances; an update;Expert Review of Clinical Pharmacology;2023-11-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3